Cargando…

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis

BACKGROUND: Limited data exist regarding impact of IDH mutations in Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs). Prognostic significance of IDH mutations was asessed in 184 Ph-negative MPN patients - 107 essential thrombocythemia (ET) and 77 primary myelofibrosis (PMF). MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yonal-Hindilerden, Ipek, Daglar-Aday, Aynur, Hindilerden, Fehmi, Akadam-Teker, Basak, Yilmaz, Ceylan, Nalcaci, Meliha, Yavuz, Akif Selim, Sargin, Deniz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676343/ https://www.ncbi.nlm.nih.gov/pubmed/26668680 http://dx.doi.org/10.14740/jocmr2405w

Ejemplares similares

Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
por: Yönal, İpek, et al.
Publicado: (2016)

The Burden of JAK2V617F Mutated Allele in Turkish Patients With Myeloproliferative Neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2017)

Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2023)

Hairy cell leukemia followed by polycythemia vera: report of the first case
por: Ipek, Yonal-Hindilerden, et al.
Publicado: (2016)

MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case
por: Yönal-Hindilerden, İpek, et al.
Publicado: (2018)

Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia: Long-Term Follow-Up of 15 Cases
por: Hindilerden, Fehmi, et al.
Publicado: (2017)

Comparison of Response to Rituximab Therapy in Adults with Refractory Symptomatic Immune Thrombocytopenia According to the Presence of Accessory Spleen
por: Hindilerden, Fehmi, et al.
Publicado: (2022)

Comprehensive mastocytosis data analysis from a single center
por: Tiryaki, Tarık Onur, et al.
Publicado: (2023)

Hairy Cell Leukemia Presenting with Isolated Skeletal Involvement Successfully Treated by Radiation Therapy and Cladribine: A Case Report and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2015)

Primary B-Cell Mucosa-Associated Lymphoid Tissue Lymphoma of the Hard Palate and Parotid Gland: Report of One Case and Review of the Literature
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2016)

Aleukemic Leukemia Cutis Manifesting with Disseminated Nodular Eruptions and a Plaque Preceding Acute Monocytic Leukemia: A Case Report
por: Yonal, Ipek, et al.
Publicado: (2011)

Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2017)

Plasmacytoma of the Nasolacrimal Duct Simulating Dacryocystitis: An Uncommon Presentation for Extramedullary Relapse of Multiple Myeloma
por: Kalayoglu-Besisik, Sevgi, et al.
Publicado: (2012)

Budd-Chiari Syndrome: An Unusual Complication of AL Amyloidosis
por: Tiryaki, Tarık Onur, et al.
Publicado: (2020)

Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
por: Hindilerden, Fehmi, et al.
Publicado: (2021)

Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin’s Lymphoma
por: Yonal-Hindilerden, Ipek, et al.
Publicado: (2021)

A Case with Hepatic Involvement Mimicking Metastatic Disease in Multiple Myeloma
por: Erciyestepe, Mert, et al.
Publicado: (2020)

Immune Thrombocytopenia in a Very Elderly Patient With Covid-19
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

A misleading presentation of T cell/histiocyte rich B-cell lymphoma mimicking osteomyelitis
por: Özpolat, Tahsin, et al.
Publicado: (2018)

Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids
por: Hindilerden, Fehmi, et al.
Publicado: (2020)

A Rare Cause of Unexplained Refractory Iron Deficiency Anemia: Unicentric Plasma-Cell Type Castleman’s Disease
por: Kalayoğlu Beşışık, Sevgi, et al.
Publicado: (2016)

The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report
por: Yonal, Ipek, et al.
Publicado: (2012)

P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
por: Konyaoglu, Hilal, et al.
Publicado: (2023)

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?
por: ERDEM, Simge, et al.
Publicado: (2021)

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
por: Tefferi, A, et al.
Publicado: (2010)

Recent advances in understanding myelofibrosis and essential thrombocythemia
por: Vainchenker, William, et al.
Publicado: (2016)

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
por: Özbalak, Murat, et al.
Publicado: (2022)

A case of chronic lymphocytic leukemia with massive ascites
por: Yonal, Ipek, et al.
Publicado: (2012)

The importance of cytogenetics in polycythemia vera, primary myelofibrosis and essential thrombocythemia
por: Conchon, Monika
Publicado: (2011)

Population pharmacokinetics of fedratinib in patients with myelofibrosis, polycythemia vera, and essential thrombocythemia
por: Ogasawara, Ken, et al.
Publicado: (2019)

The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study
por: Erdal, Gulcin Sahingoz, et al.
Publicado: (2021)

Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis
por: Tefferi, A, et al.
Publicado: (2017)

Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
por: Carobbio, Alessandra, et al.
Publicado: (2023)

Cytogenetics, JAK2 and MPL mutations in polycythemia vera, primary myelofibrosis and essential thrombocythemia
por: dos Santos, Leonardo Caires, et al.
Publicado: (2011)

P1047: REAL-WORLD SAFETY OF RUXOLITINIB IN PATIENTS WITH INTERMEDIATE OR HIGH RISK OF PRIMARY MYELOFIBROSIS, POST-POLYCYTHEMIA VERA MYELOFIBROSIS OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS IN CHINA
por: Xu, Z., et al.
Publicado: (2022)

Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
por: Schalling, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f4qm3ppi1ckr78f4rbe2s66vtt